Evidence map›Paper›PMID 16387870›Full record

ArticleGenetics2006

A versatile and efficient gene-targeting system for Aspergillus nidulans.

Tania Nayak, Edyta Szewczyk, C Elizabeth Oakley, Aysha Osmani, Leena Ukil, Sandra L Murray, Michael J Hynes, Stephen A Osmani, Berl R Oakley

Abstract read
In one paragraph

Article in Genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 318 papers.

0numbers the graph read from it
0cells of the map it votes in
318citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

318 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Engineering Industrial Strain ofAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Functional analysis ofMycoscience · 2026
    Article
  6. VapA/Scs2 sustains polarized growth inMicrobial cell (Graz, Austria) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Engineering of Global Transcriptional Regulators (GTRs) inJournal of fungi (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

258 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tania NayakDepartment of Molecular Genetics, The Ohio State University, Columbus 43210, USA.
Edyta Szewczyk
C Elizabeth Oakley
Aysha Osmani
Leena Ukil
Sandra L Murray
Michael J Hynes
Stephen A Osmani
Berl R Oakley

Funding

THE MOLECULAR BIOLOGY OF ORGNELLAR TRANSLOCATIONR01GM031837 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OAKLEY, BERL RAY · 1985 to 2009
$2.9M
NIGMS NIH HHS R01 GM031837
6 · The paper itself

Abstract

Aspergillus nidulans is an important experimental organism, and it is a model organism for the genus Aspergillus that includes serious pathogens as well as commercially important organisms. Gene targeting by homologous recombination during transformation is possible in A. nidulans, but the frequency of correct gene targeting is variable and often low. We have identified the A. nidulans homolog (nkuA) of the human KU70 gene that is essential for nonhomologous end joining of DNA in double-strand break repair. Deletion of nkuA (nkuA delta) greatly reduces the frequency of nonhomologous integration of transforming DNA fragments, leading to dramatically improved gene targeting. We have also developed heterologous markers that are selectable in A. nidulans but do not direct integration at any site in the A. nidulans genome. In combination, nkuA delta and the heterologous selectable markers make up a very efficient gene-targeting system. In experiments involving scores of genes, 90% or more of the transformants carried a single insertion of the transforming DNA at the correct site. The system works with linear and circular transforming molecules and it works for tagging genes with fluorescent moieties, replacing genes, and replacing promoters. This system is efficient enough to make genomewide gene-targeting projects feasible.

Indexed as

Antigens, NuclearAspergillus fumigatusAspergillus nidulansDNA-Binding ProteinsGene TargetingGenetic MarkersHumansKu AutoantigenMutationPlasmidsSequence Homology, Nucleic AcidAntigens, NuclearDNA-Binding ProteinsGenetic MarkersKu AutoantigenXrcc6 protein, human

Identifiers

PMID16387870
PMCPMC1456264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.